Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
09/2006
09/26/2006US7112568 an anti-allergic agent, comprising a molecule having at least a first segment competent for importation of the molecule into mast cells, and a second segment for having an anti-allergic effect within the mast cells
09/26/2006US7112426 Human cAMP-dependent protein kinase beta-catalytic subunit
09/26/2006US7112421 Nucleic acids encoding BAFF receptor, chimeric proteins and methods and compositions related thereto
09/26/2006US7112415 Method of preparing cell cultures from biological specimens for assaying a response to an agent
09/26/2006US7112324 CD 19×CD3 specific polypeptides and uses thereof
09/26/2006CA2278694C Sulfamide-metalloprotease inhibitors
09/21/2006WO2006099480A2 Stress proteins and peptides and methods of use thereof
09/21/2006WO2006098603A2 Composition comprising isoorientin for suppressing histamine
09/21/2006WO2006098353A1 External preparation
09/21/2006WO2006097547A1 Use of 5'-methylthioadenosine (mta) in the prevention and/or treatment of autoimmune diseases and/or transplant rejection
09/21/2006WO2006097458A1 Novel combination
09/21/2006WO2006097327A2 Soluble btnl2 protein useful to inhibit inflammatory disorders
09/21/2006WO2006097273A1 Compounds having immunomodulator activity
09/21/2006WO2006096911A1 Novel potassium channel blockers and uses thereof
09/21/2006WO2006002422A9 Compounds for immunopotentiation
09/21/2006WO2005084662A8 The euphorbia lunulate bge extractant and production method and use thereof
09/21/2006WO2004089282A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/21/2006US20060212109 Delivery of therapeutic capable agents
09/21/2006US20060211764 Cell activator, process for producing cell activator and apparatus therefor
09/21/2006US20060211725 Use
09/21/2006US20060211704 2,4-Disubstituted thiazolyl derivatives
09/21/2006US20060211696 IMIDAZO[1,2-b]PYRIDAZINE COMPOUND
09/21/2006US20060211694 antiinflammatory agent for treating asthma and chronic pulmonary inflammatory disease
09/21/2006US20060211661 24 hydroxyvitamin d, analogs and uses thereof
09/21/2006US20060211658 Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator
09/21/2006US20060211656 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
09/21/2006US20060211651 Persulfated oligosaccharide acting on selectins and chemokine
09/21/2006US20060211607 Somatostatin-dopamine chimeric analogs
09/21/2006US20060211602 Use of alanyl aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors
09/21/2006US20060210567 Antibodies against pd-1 and uses therefor
09/21/2006US20060210550 Angiogenesis inducer
09/21/2006US20060210535 Means for regulating the expression of human isoforms of ant
09/21/2006US20060210531 Agent eleveting dendritic cell precursor level in blood
09/21/2006CA2602312A1 Soluble btnl2 protein useful to inhibit inflammatory disorders
09/21/2006CA2601557A1 Use of 5'-methylthioadenosine (mta) in the prevention and/or treatment of autoimmune diseases and/or transplant rejection
09/21/2006CA2601123A1 External preparation
09/21/2006CA2601046A1 Composition comprising isoorientin for suppressing histamine
09/21/2006CA2600690A1 Recombinant e-selectin made in insect cells
09/21/2006CA2599218A1 Cat allergen conjugates and uses thereof
09/20/2006EP1703014A1 Allergen suppressor, allergen-suppression processed fiber and method of producing the same
09/20/2006EP1702926A1 Levulose glucoselipid a analogue
09/20/2006EP1702920A1 Pyrazole compounds useful as protein kinase inhibitors
09/20/2006EP1702910A1 Octahydronaphthalene derivative and medicine
09/20/2006EP1702624A1 Immunotherapeutic stress protein-peptide complexes against cancer
09/20/2006EP1702622A1 Soluble BTNL2 protein useful to inhibit inflammatory disorders
09/20/2006EP1702620A1 Immunopotentiator and method of enhancing immunological activity with the same
09/20/2006EP1702617A1 Cannabimimetic indole derivatives
09/20/2006EP1701955A1 Arylalkenyl and arylalkynyl substituted imidazoquinolines
09/20/2006EP1701933A1 Novel compounds
09/20/2006EP1701736A1 Therapeutic agents and uses therefor
09/20/2006EP1701720A1 Use of chp as an inhibitor of glutathione s-transferases and collagen iv
09/20/2006EP1701711A1 Nanoparticles for delivery of a pharmacologically active agent
09/20/2006EP1554253A4 Imidazolium cxcr3 inhibitors
09/20/2006EP1353916B1 Pyrazole compounds useful as protein kinase inhibitors
09/20/2006EP1292621B1 Compositions for treating autoimmune disease
09/20/2006EP1280897B1 Regulation of nf-at interacting protein nip 45 variant
09/20/2006EP1276491B1 Tamandarin and didemnin analogs and methods of making and using them
09/20/2006EP1246841B1 Transcription factors containing two potential dna binding motifs
09/20/2006EP1218049B1 Apparatus for relieving headaches, rhinitis and other common ailments
09/20/2006EP1051191B1 CD154 BLOCKADE THERAPY FOR PANCREATIC ISLET TISSUE TRANSPLANTATION in primates
09/20/2006EP0975361B1 Methods of modulating immune coagulation
09/20/2006EP0923582B1 Substituted 6,5-hetero-bicyclic derivatives
09/20/2006EP0799037B1 Compositions for treating allergic rhinitis and other disorders comprising descarboethoxyloratadine
09/20/2006CN1835977A CD20-binding polypeptide compositions
09/20/2006CN1835758A Glycyrrhizin high-concentration preparation
09/20/2006CN1835750A Oxime substituted imidazo-containing compounds
09/20/2006CN1833720A Biological answer-reply regulator of microbe extracting factor
09/20/2006CN1833709A Honey capsule
09/20/2006CN1833543A Health beverage-'chenmei juice'
09/20/2006CN1276549C Apparatus for a quick release safety connector assembly
09/20/2006CN1275978C Oslasodine hydrochloride preparing process
09/20/2006CN1275968C Non crystalline tricyclic triazolobenzazepine derivative
09/20/2006CN1275954C Hydroxamic acid derivatives
09/20/2006CN1275917C Glucocorticoid receptor modulators
09/20/2006CN1275916C Novel intermediates useful for the preparation of antihistaminic piperidine derivatives
09/20/2006CN1275648C Vaccin composition, preparation method and use thereof
09/20/2006CN1275606C Medical usage of simonder wood oil
09/20/2006CN1275604C Oral compositions for white blood cell activation and proliferation
09/20/2006CN1275594C Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
09/20/2006CN1275551C Green healthy beverage
09/19/2006US7109364 Compounds containing a specific branched chain end terminal group, which is isopropyl, sec.-butyl, or tert.-butyl; a polar leading group, and long chain aliphatic, non-cyclic, saturated or nonsaturated linking groups
09/19/2006US7109354 Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
09/19/2006US7109342 Antiinflammatory agents; antiallergens; autoimmune diseases
09/19/2006US7109331 Antiprotozoa agents; 4-pyrrolidine pyrrolo(3,2-d)pyrimidine and 4-pyrrolidine pyrazolo(4,3-d)pyrimidine derivatives
09/19/2006US7109323 lyophilization of an aqueous mixture comprising a boronic add compound and a compound having at least two hydroxyl groups produces a stable composition that readily releases the boronic acid compound upon dissolution in aqueous media
09/19/2006US7109296 Used to identify modulators of the 5-HT3 serotonin receptor complex, and to reconstitute a more realistic physiological 5-HT3 receptor response in recombinant systems
09/19/2006US7109291 Compounds capable of modulating the activity and stimulating the production of a catalytic antibody
09/19/2006US7109246 Pharmaceutical compositions comprising an amphoteric surfactant an alkoxylated cetyl alcohol and a polar drug
09/19/2006US7109202 Such as 3-(2-(6-methyl-pyridin-2-ylamino)-5-(1,2,4)triazol-1-yl-thiazol-4 -yl)benzonitrile for treatment of inflammatory or obstrucive airways diseases
09/19/2006US7109199 5-(2,3-Difluorophenyl)-1H-pyrazolo(3,4-c)pyridazin-3-ylamine, e.g.; an enzyme inhibitor of GSK-3, a serine/threonine protein kinase; neuroprotectants in treatment of acute stroke, neurotraumatic injuries and diabetic conditions
09/19/2006US7109196 1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders
09/19/2006US7109194 3-heteroaryl-3, 5-dihydro-4-oxo-4H-pyridazino[4, 5-b]indole-1-carboxamide derivatives their preparations and therapeutic use
09/19/2006US7109189 Mitochondrially targeted antioxidants
09/19/2006US7109183 Phosphohalohydrins, process for the production thereof and use thereof
09/19/2006US7109176 For therapy of inflammatory diseases and conditions in humans and animals
09/19/2006US7109031 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
09/19/2006US7109026 Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment
09/19/2006US7108987 Factors participating in degranulation of mast cells, DNAs encoding the same, method of screening of these factors and the inhibitors
09/19/2006US7108868 Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
09/19/2006US7108858 Immunological protein